The focus on pharmaceuticals is expected to strengthen the hands of the National Pharmaceutical Pricing Authority (NPPA), the drug price regulator.
The government is also expected to streamline the pharma-related regulatory functions of various ministries through the new department.
According to sources, though the committee of secretaries will consider the proposal, it is not yet clear whether it will decide to include several administrative powers related to the pharma sector that are currently dispersed between departments of biotechnology, health, and science and technology, under the ambit of the new department. The formation of a new department does not require Cabinet approval.
The leaders of the Left parties had recently urged Prime Minister Manmohan Singh to create a separate department or ministry for pharmaceuticals. They highlighted the problem of multiple regulatory authorities in the sector.
The draft pharma policy, under consideration of a group of ministers headed by Agriculture Minister Sharad Pawar, had also highlighted the need for more emphasis on pharmaceuticals by the department.
It had suggested that the department of chemicals and petrochemicals, the nodal department for the pharma industry, should be renamed as the
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
